Johnson & Johnson on Tuesday forecast annual profit above Wall Street estimates as it bets on stronger demand for its pharmaceuticals products and a...
Johnson & Johnson's highly anticipated HIV vaccine failed to demonstrate adequate protection in a clinical trial involving more than 2,600 young women in sub-Saharan...
A booster dose of Johnson & Johnson's COVID-19 vaccine sharply increased levels of antibodies, according to interim data from two early-stage trials, the company...
Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed strong promise against the Delta variant and other emerging strains and also...
A popular baby products brand said on Friday it is recalling around 33,000 bottles of baby powder in the United States after US health regulators found trace amounts of asbestos in samples
NEW YORK/LOS ANGELES: Johnson & Johnson’s statement was unequivocal.
"The FDA has tested Johnson's talc since the '70s. Every single time it did not contain...